Reviewed 11-01-2003
Get
Web page suited for printing
Email
this to a friend or colleague
Table of Contents (click to jump to sections)
What is Diabetic Neuropathy?
Is there any treatment?
What is the prognosis?
What research is being done?
Organizations
Additional
resources from MEDLINE plus
What is Diabetic Neuropathy?
Diabetic neuropathy is a peripheral nerve disorder caused by diabetes. The
symptoms of diabetic neuropathy are often slight at first. In fact, some mild
cases may go unnoticed for a long time. Numbness, pain, or tingling in the feet,
or legs may, after several years, lead to weakness in the muscles of the feet.
Occasionally, diabetic neuropathy can flare up suddenly and affect specific
nerves so that an affected individual will develop double vision or drooping
eyelids, or weakness and atrophy of the thigh muscles. Nerve damage caused by
diabetes generally occurs over a period of years and may lead to problems with
the digestive tract and sexual organs, which can cause indigestion, diarrhea or
constipation, dizziness, bladder infections, and impotence. The loss of
sensation in the feet may increase the possibility for foot injuries to go
unnoticed and develop into ulcers or lesions that become infected.
Is there any treatment?
The goal of treating diabetic neuropathy is to relieve discomfort and prevent
further tissue damage. The first step is to bring blood sugar levels under
control by diet and medication. Another important part of treatment involves
taking special care of the feet. Analgesics, low doses of antidepressants, and
some anticonvulsant medications may be prescribed for relief of pain, burning,
or tingling. Some patients may find that walking regularly, taking warm baths,
or using elastic stockings may help relieve leg pain.
What is the prognosis?
The prognosis for diabetic neuropathy depends largely on how well the underlying
condition of diabetes is handled. Treating diabetes may halt progression and
improve symptoms of the neuropathy, but recovery is slow. The painful sensations
of diabetic neuropathy may become severe enough to cause depression in some
patients.
What research is being done?
The NINDS conducts and supports research on diabetic neuropathy to increase
understanding of the disorder and find ways to prevent and cure it. New
medications are currently being examined to assess improvement or stabilization
of neuropathic symptoms.
Select
this link to view a list of all studies currently seeking patients.
Organizations
American Chronic Pain Association (ACPA)
P.O. Box 850
Rocklin, CA 95677-0850
ACPA@pacbell.net
http://www.theacpa.org
Tel: 916-632-0922 800-533-3231
Fax: 916-632-3208
National Chronic Pain Outreach Association (NCPOA)
P.O. Box 274
Millboro, VA 24460
ncpoa@cfw.com
http://www.chronicpain.org
Tel: 540-862-9437
Fax: 540-862-9485
American Diabetes Association
1701 North Beauregard Street
Alexandria, VA 22311
customerservice@diabetes.org
http://www.diabetes.org
Tel: 800-DIABETES (342-2383) 703-549-1500
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health, DHHS
31 Center Drive, Rm. 9A06 MSC 2560
Bethesda, MD 20892-2560
http://www.niddk.nih.gov
Tel: 301-496-3583
National Institute of Dental and Craniofacial Research (NIDCR)
National Institutes of Health, DHHS
45 Center Dr, Rm. 4AS19 MSC 6400
Bethesda, MD 20892-6400
nidrinfo@od31.nidr.nih.gov
http://www.nidr.nih.gov
Tel: 301-496-4261
Juvenile Diabetes Research Foundation, International
120 Wall Street
New York, NY 10005-4001
info@jdrf.org
http://www.jdrf.org
Tel: 800-533-CURE (-2873)
Fax: 212-795-9595
NINDS health-related
material is provided for information purposes only and does not necessarily
represent endorsement by or an official position of the National Institute of
Neurological Disorders and Stroke or any other Federal agency. Advice on the
treatment or care of an individual patient should be obtained through
consultation with a physician who has examined that patient or is familiar with
that patient's medical history.
All NINDS-prepared information is in the public domain and may be freely
copied. Credit to the NINDS or the NIH is appreciated.
Provided by:
The National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892